Company: XERI
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001477932-25-001010
Chunk: 5

Company: XERIANT, INC.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
AUDITED                     Common                 Series A Preferred Stock    Series B Preferred Stock    Common Stock   Stock  To Be    Additional Paid in    Accumulated     Non-Controlling       Shares   Amount  Shares   Amount   Shares  Amount  Issued   Capital   Deficit  Interest   Total  Balance June 30, 2023  757,395  $8   1,000,000  $10   389,433,144  $3,894  $51,950  $19,789,793  $(23,638,461 ) $(2,827,294 ) $(6,620,100 )                                             Conversion of Series A Preferred to Common Stock  (5,000 )  -   -   -   5,000,000   50   -   (50 )  -   -   -                                              Conversion of convertible notes payable and accrued interest into common stock  -   -   -   -   6,600,000   66   -   65,934   -   -   66,000                                              Net loss  -   -   -   -   -   -   -   -   (334,090 )  (7,922 )  (342,012 )                                             Balance September 30, 2023  752,395  $8   1,000,000  $10   401,033,144  $4,010  $51,950  $19,855,677  $(23,972,551 ) $(2,835,216 ) $(6,896,112 )                                             Conversion of Series A Preferred to Common Stock  (18,500 )  (1 )  -   -   18,500,000   185   -   (185 )  -   -   (1 )                                             Conversion of convertible notes payable and accrued interest into common